Stem Cell Center of Competence ::: Uni Basel, Switzerland
 

 
    Search    
 
  Research
     
 
   
 
 


 
 

 
   

back

   

Home > Research > Topics > R. Passweg


 

Prof. Dr. med. Jakob R. Passweg

 
 

Chefarzt
Klinik für Hämatologie
Bereich Innere Medizin
Universitätsspital Basel
Petersgraben 4
4031 Basel / Switzerland  
 

 
E-mail jpassweg@uhbs.ch
Phone +41 61 328 72 77
Fax +41 61 265 44 50
 
Homepage
 
 
Prof Jakob Passweg is chair of hematology at the Basel University Hospital. He is particularly interested in studying outcome of patients receiving hematopoetic stem cell transplantation and in improving results of hematopoetic stem cell transplantation through immune intervention such as adoptive transfer of immune reactive cells. He has served in the past on the board of the European Group of Blood and Marrow Transplantation, is Co-Editor of the journal BMT and is currently President of the Swiss Cancer League.

Selected original publications
  • Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kühne T, Favre G and Gratwohl A. (2004). Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia 18:1835-1838.
  • Cesaro S, Marsh J, Tridello G, Rovò A, Maury S, Montante B, Masszi T, Van Lint MT, Afanasyev B, Iriondo Atienza A, Bierings M, Carbone C, Doubek M, Lanino E, Sarhan M, Risitano A, Steinerova K, Wahlin A, Pegoraro A and Passweg JR. (2010). Retrospective Survey on the Prevalence and Outcome of Prior Autoimmune Diseases in Patients with Aplastic Anemia Reported to the Registry of the European Group for Blood and Marrow Transplantation. Acta Haematol 124:19-22. Weblink
  • Passweg JR, Giagounidis AA, Simcock M, Aul C, Dobbelstein C, Stadler M, Ossenkoppele G, Hofmann WK, Schilling K, Tichelli A and Ganser A. (2010) Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive Care--SAKK 33/99. J Clin Oncol 29:303-309. Weblink
  • Tichelli A, Schrezenmeier H, Socié G, Marsh J, Bacigalupo A, Dührsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, Höchsmann B, Barrois A, Champion K and Passweg JR. (2011). A randomized controlled study in newly-diagnosed severe aplastic anemia patients receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the EBMT. Blood in press. Weblink


Reviews

  • Passweg JR, Marsh JC. (2010). Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Am Soc Hematol Educ Program 2010:36-42. Weblink

 


 



 
 
 
           
     
       Copyright © 2011 BSCN